<div>
  <p>
  </p>
  <ul>
    <li>
      <p>
        Vouch, a business insurance provider, and Vanta, a trust management platform, have partnered to offer embedded cyber insurance solutions.
      </p>
    </li>
    <li>
      <p>
        The partnership allows Vanta customers to purchase cyber insurance directly within the Vanta platform, streamlining the process of obtaining coverage and satisfying SOC 2 requirements. This integration aims to simplify and accelerate compliance for startups by providing instant access to cyber insurance, eliminating the need for manual processes and potential delays in compliance milestones.
      </p>
    </li>
    <li>
      <p>
        The collaboration seeks to address companies' challenges in obtaining cyber insurance, offering a seamless, integrated solution that aligns with Vanta's goal of streamlining the SOC 2 process and Vouch's vision of providing instantly accessible insurance coverage.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.prnewswire.com/news-releases/vouch-and-vanta-bring-embedded-cybersecurity-insurance-to-vanta-platform-302249588.html">
      Press release
    </a>
  </p>
</div>


Cyber Insurance

PROMINENT_CATEGORY

<div>
 
 <p>Vouch, a business insurance provider, and Vanta, a trust management platform, are collaborating to provide cyber insurance solutions directly within the Vanta platform.</p>
 <p>The integration aims to make compliance simpler and faster for startups by providing instant access to cyber insurance, bypassing the need for manual procedures and potential compliance delays. This move is geared towards addressing companies' issues in securing cyber insurance and fitting with Vanta's aim of simplifying the SOC 2 process and Vouch's approach of delivering instantly available insurance coverage.</p>
 
</div>

Vouch and Vanta partner to offer embedded cyber insurance on Vanta platform

Leveraging personal data for custom-fit diagnosis and treatment

Precision Medicine

<div>
 <p>Biotechnology company VerImmune has successfully raised USD 4.5 million in a pre-Series A investment round. The funding was led by Beiley Biofund and included participation from new investor Dr. John Ballantyne as well as existing investors such as Proxima Ventures, Mana Ventures, and Gaingels. As a part of the funding deal, a GM of Beiley and a former partner at Agent Capital will join VerImmune's board of directors.</p>
 <p>The raised capital will be utilised by the company to advance the development of its novel virus-inspired particle (ViP) immunotherapeutics, which include the lead product candidate VERI-101. This candidate, based on VerImmune’s proprietary ViP platform, works by using the concept of anti-tumor immune redirection. This unique mechanism leads the pre-existing immune memory of the body, specifically against cytomegalovirus infections, to target and eradicate cancer cells.</p>
 <p>VerImmune's approach is rooted in its ViP technology platform, which is utilized to build a unique immunotherapy approach against cancer. The leading product candidate, VERI-101, channels the body's existing immunity from past infections or vaccinations received in childhood to fight against cancer. This approach aims to deliver new treatment options for patients who have limited alternatives or have developed resistance to existing therapies.</p>
</div>

VerImmune raises USD 4.5 million in pre-Series A funding to advance virus-inspired particle immunotherapeutics

<div>
 <p>Genomics firm, NuProbe, has teamed up with Angle in a strategic partnership, with an aim to integrate next-gen sequencing (NGS) technology into oncology research. The collaboration will utilize NuProbe’s NGS panel for the inspection of circulating tumor cells (CTCs) and for the joint analysis of CTCs and circulating tumor DNA (ctDNA).</p>
 <p>The alliance aims to accelerate the commercial launch of Angle’s first pan-cancer molecular sequencing test. This will be achieved with the assistance of the NGS panel, selected by Angle from a range of multi-gene assays offered by various providers.</p>
 <p>NuProbe is a genomics enterprise dedicated to the creation of highly sensitive research assays in order to identify and monitor low-frequency mutations, gene fusions, and changes in gene copy numbers within the field of oncology. NuProbe’s main technology, blocker displacement amplification (BDA), allows the detection of low-frequency mutations. It is designed to be adaptable with multiple platforms such as qPCR, ddPCR, NGS, and nanopore sequencing. The company's array of offerings includes a pan-cancer NGS panel that reportedly enables the detection of in excess of 6,500 DNA mutations in 61 clinically important genes.</p>

</div>

NuProbe partners with Angle for next-gen sequencing assay on CTCs and ctDNA

<div>
 <p>ImpriMed, a company specializing in veterinary medicine, has extended its AI-driven drug response predictions to human oncology, starting with blood cancers such as multiple myeloma and acute myeloid leukemia.</p>
 <p>The expanded services in human oncology encompass genomic analysis, the inclusion of machine learning (ML), and ex vivo drug sensitivity testing for newly diagnosed cases of multiple myeloma, acute myeloid leukemia, and non-Hodgkin lymphoma. These methods aim to predict treatment outcomes and the likelihood of early disease progression, as well as analyze a patient's drug responses and survival outcomes, and devise precise treatment protocols.</p>
 <p>ImpriMed is a biotech company that utilizes AI to forecast cancer treatment results, branching out from veterinary to human oncology. After proving successful in veterinary applications, such as canine blood cancers, ImpriMed has applied its AI-driven strategies to human cancers, mainly concentrating on blood cancers like multiple myeloma, acute myeloid leukemia, and non-Hodgkin lymphoma. The company's technology leverages ex vivo drug sensitivity testing, combined with ML, to evaluate individual patient's reactions to specific treatments, facilitating personalized therapy.</p>
 
</div>

ImpriMed expands AI-powered precision medicine services to oncology

<div>
 <p>AdvancedDx Biological Laboratories (ABL) and Complete Genomics have entered a partnership aimed at co-promoting ABL's DeepChek assays and software with Complete Genomics' DNBSEQ genome sequencing platforms. The deal targets microbiology laboratories across the United States. No financial or other specific details regarding the agreement have been disclosed.</p>
 <p>The collaboration intends to offer next-generation sequencing (NGS)-based end-to-end solutions so as to equip microbiology laboratories with assays, sequencing systems, and downstream analysis software required for a wide range of medical applications. These applications include human immunodeficiency virus (HIV), viral hepatitis (HBV/HCV/HDV), respiratory viruses (Influenza, SARS-CoV-2, RSV..), cytomegalovirus, herpes simplex virus, BK polyomavirus, and tuberculosis.</p>
 <p>ABL, an US-based affiliate of ABL Diagnostics, is known for specializing in providing molecular diagnostic solutions. The company primarily focuses on infectious diseases such as HIV, hepatitis B and C, tuberculosis, and SARS-CoV-2. Along with DeepChek, ABL also offers the UltraGene assays, which are specifically designed for next-generation sequencing (NGS) and real-time PCR applications. The DeepChek platform, in particular, is utilized for genotyping solutions in HIV. It aids in tracking mutations and drug resistance, thereby enabling the optimization of treatment strategies.</p>
 
</div>

ABL partners with Complete Genomics to co-promote NGS-based solutions

Empowering Tomorrow's Innovations with Generative AI Infrastructure

Generative AI Infrastructure

<div>
 <p>Open-source LLMs specialist, Together AI, has launched the Together Enterprise Platform. The platform supports AI deployment in both virtual private cloud (VPC) and on-premises settings.</p>
 <p>The new platform enables organisations to manage and operate AI models within their own private cloud deployment, offering flexibility and scalability to Together's cloud. The platform also boasts of improving AI inference workload performance by double or triple, whilst reducing the required hardware by 50%.</p>
 <p>Together AI alleges that its platform can systematically manage the use of multiple AI models within a single application or process. This affords enterprises the ability to use diverse models in unison. An innovative "Mixture of Agents" method has also been introduced by the company, which merges multi-model agentic AI with a system that can be trained for continuous enhancement.</p>
 
</div>

Together AI launches enterprise AI platform for private cloud deployment to improve performance of AI inference workloads

<div>
 <p>A new information retrieval (IR) methodology, known as Promptriever, has been put forward by researchers at Johns Hopkins University and Samaya AI. Allegedly, it's the first retrieval model with the ability to be prompted just like a language model and also the first of its kind to present zero-shot promptable retriever capabilities.</p>
 <p>Promptriever maintains its retrieval abilities by utilizing a training paradigm that aids the model in following written instructions. This method employs wider-ranging training examples containing augmented user queries combined with explicit instructions and illustrative negative instances.</p>
 <p>To facilitate training, the research team built a dataset comprising around 500,000 examples drawn from MS Marco data, and enriched with the likes of Llama-3-70 billion-Instruct and GPT-4. This dataset has been published on Hugging Face, making it accessible to other researchers.</p>
 <p>Findings indicate that Promptriever demonstrates superior performance to other bi-encoder models and comes close to emulating cross-encoder models for tasks involving following instructions, with its standard retrieval quality evidently unimpeded.</p>
</div>

Promptriever introduces instruction-following capabilities to LLM information retrieval and training

Generating, collecting, and analyzing enterprise data will never be the same.

Edge Computing

ANALYST_QUICK_TAKE

<div>
 <p>Gcore, a company that offers solutions in edge AI, cloud, network, and security, has introduced Gcore WAAP. This is an AI-based web application and API protection solution.</p>
 <p>This innovative Gcore WAAP solution brings together a web application firewall, DDoS protection, bot management, and API security into a single solution. It observes traffic at the edge, utilizes AI to identify and mitigate potential threats, and adjusts to shield from zero-day attacks.</p>
 
</div> <p><b>Analyst QuickTake:<br>
</b> Gcore's launch of the WAAP solution follows the company's USD 60 million <a href="https:<br>
//sp-edge.com/updates/31865"> fundraising in July 2023 </a> , allocated to expanding and enhancing its technology offerings. By investing in AI-driven protection tools like WAAP, Gcore is positioning itself to better compete in the growing cloud security market.</p>

Gcore launches AI-powered security platform for web applications and APIs

INCUMBENTS_PRESENT

<div>
 <p>Intel's subsidiary, Altera which is dedicated to field-programmable gate arrays (FPGAs) has unveiled new information about its forthcoming Agilex 3 chip series.</p>
 <p>These chips are equipped with 25,000–135,000 programmable logic elements, a dual-core ARM-based CPU, and transceivers for multimedia processing at rates of up to 12.5 Gbps. They also support LPDDR4 memory.</p>
 <p>Intel suggests that these chips will be utilized in devices such as connected gadgets, industrial robots, and self-driving cars, declaring that they offer superior cybersecurity and exhibit a 1.9x improvement in performance compared to their precursors.</p>
 
</div>

Intel shares details about upcoming Agilex 3 chips

Electrifying passenger and commercial travel

EV Economy

<div>
 <p>Swedish EV battery and energy storage manufacturer, Northvolt, has announced 1,600 job cuts across three sites due to challenges in the EV industry. This includes suspending the expansion of its Northvolt Ett gigafactory located in Skellefteå, northern Sweden.</p>
 <p>Specifically, the layoffs will be distributed as 1,000 in Skellefteå, 400 in Västerås, and 200 in Stockholm. These layoffs are based on ongoing union negotiations following financial difficulties which led to weeks of uncertainty for the company.</p>
 <p>Moving forward, Northvolt's priority will be to expand operations in Skellefteå and produce battery cells with a production capacity of 16GWh. This is a decrease from the initially planned annual capacity of 30GWh for the Ett project.</p>
 
</div>

Northvolt cuts 1,600 jobs amid EV industry challenges

Additive manufacturing makes objects by systematically adding material via a CAD program

Additive Manufacturing

<div>
 <p>Rapid Fusion, a company affiliated with EVO 3D, has introduced Apollo, a large-format robotic additive manufacturing system. The system is crafted for swift production of sizable parts and molds, catering to manufacturers in industries such as automotive, aerospace, and furniture.</p>
 <p>The Apollo system employs pellet extrusion printing, which includes the use of the PE320 Pellet Extruder, a distinct control system, and a Kuka robotic arm. This allows users to print components within a sizable build volume of 2 m x 3 m x 3 m. With a cost of GBP 250,000, Rapid Fusion anticipates its sale to exceed GBP 4 million (USD 5.35 million) in the debut year.</p>
 <p>Furthermore, the company has forged international reseller agreements with CNC World in the UK, Hyperion in Australia, Maptec in Dubai, and ACCUFACTURE in the US.</p>
</div>

All Updates

Vouch and Vanta partner to offer embedded cyber insurance on Vanta platform

VerImmune raises USD 4.5 million in pre-Series A funding to advance virus-inspired particle immunotherapeutics

NuProbe partners with Angle for next-gen sequencing assay on CTCs and ctDNA

ImpriMed expands AI-powered precision medicine services to oncology

ABL partners with Complete Genomics to co-promote NGS-based solutions

Together AI launches enterprise AI platform for private cloud deployment to improve performance of AI inference workloads

Promptriever introduces instruction-following capabilities to LLM information retrieval and training

Gcore launches AI-powered security platform for web applications and APIs

Intel shares details about upcoming Agilex 3 chips

Northvolt cuts 1,600 jobs amid EV industry challenges

Rapid Fusion launches Apollo, a large-format robotic 3D printing system

Cyber Insurance

Vouch and Vanta partner to offer embedded cyber insurance on Vanta platform

Contact us